How is the Insmed Inc today?

The Insmed Inc today is trading in the green, up by 1.92% at 104.65.

How has Insmed Inc performed historically?

The Insmed Inc is currently trading up 1.92% on an intraday basis in the past week the index rose 6.00%. The index has been up 30.94% in the past quarter and rose 53.92% in the past year. You can view this in the overview section.

What is Insmed Inc Annual Revenue?

Insmed Inc Annual Revenue rose 19.17%, in the last year to $363.71 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Insmed Inc Annual Net Profit?

Insmed Inc Annual Net Profit fell 21.91% in the last year to $913.77 M. Its sector's average net profit growth for the last fiscal year was -14.05%.

What is Insmed Inc Price to Earning Ratio?

Insmed Inc Price to Earning Ratio is -19.62, which is negative.

What is Insmed Inc Stock Price?

Insmed Inc Stock Price rose 53.92% and underperformed its sector by 25.79% in the past year.

What is Insmed Inc Quarterly Revenue?

Insmed Inc Quarterly Revenue rose 22.94% YoY to $92.82 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Insmed Inc Quarterly Net profit?

Insmed Inc Quarterly Net profit fell 63.33% YoY to $256.58 M. Its sector's average net profit growth YoY for the quarter was -236.06%.

What is Insmed Inc Debt to Equity Ratio?

Insmed Inc Debt to Equity Ratio of 4.03 is higher than 1. This implies that company assets are financed through debt.

What is Insmed Inc Mutual Fund Holding?

Insmed Inc Mutual Fund Holding decreased by 0.08% in the last quarter to 90.33.

What is Insmed Inc Promoter Share Holding?

Insmed Inc Promoter Share Holding decreased by 0.12% in the most recent quarter to 1.84%.

What is Insmed Inc Interest Coverage Ratio?

Insmed Inc Interest Coverage Ratio is -10.34, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Insmed Inc Institutional Holding?

Insmed Inc Institutional Holding remained the same in the last quarter at 112.4%.

MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : MAJOR PHARMACEUTICALS
INSMED INC

Insmed Inc XNAS: INSM

Insmed Inc Live Share Price Today, Share Analysis and Chart

Name: Insmed Inc: Is Infosys Ltd. worth buying?
Item: Insmed Inc
Rating: 1.238500125
Author: Trendlyne DVM scores

Momentum Trap

about

Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the US for the treatment of Mycobac...

104.65 1.97 (1.92%)

New 52W High today

1.9M

XNAS Volume

XNAS 23 Jun, 2025 1:33 PM (EDT)

Low Financial Strength

16.7 / 100

Expensive Valuation

3.2 / 100

Technically Moderately Bullish

62.6 / 100

Momentum Trap These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked. View Similar Embed DVM

110

1Yr Price target upside is 5%

18 analysts

Insmed Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Insmed Inc Live Share Price Today, Share Analysis and Chart

Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the US for the treatment of Mycobac...

New 52W High today

SWOT Analysis

Insmed Inc Live Price Chart

Insmed Inc FAQ

How is Insmed Inc today?

Insmed Inc today is trading in the green, and is up by 1.92% at 104.65.

How has Insmed Inc performed historically?

Insmed Inc is currently trading up 1.92% on an intraday basis. In the past week the stock rose 6.00%. stock has been up 30.94% in the past quarter and rose 53.92% in the past year. You can view this in the overview section.